Yukihiro Hasegawa

Identification of novel human GH-1 gene polymorphisms that are associated with growth hormone secretion and height.

K. Tachibana, Y. Hasegawa, T. Tanaka,, 2000, The Journal of clinical endocrinology and metabolism.

Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients.

T. Ogata, K. Tachibana, T. Yorifuji, 2001, The Journal of clinical endocrinology and metabolism.

Measurement of free insulin-like growth factor-I using immunoradiometric assay.

Y. Hasegawa, M. Kishida, M. Takada, 1994, Journal of immunoassay.

Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets.

S. Kato, J. Yanagisawa, A. Murayama, 1998, The New England journal of medicine.

Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.

M. L. Gustafson, P. Donahoe, B. Silverman, 1997, The New England journal of medicine.

Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.

K. Tachibana, Y. Hasegawa, T. Tanaka,, 1999, The Journal of clinical endocrinology and metabolism.

The relationship between antidiuretic hormone and plasma or urine osmolalities during water restriction test and hypertonic saline loading test in normal children--a change in the apparent tubular response to AVP during these two tests.

Y. Hasegawa, Yukihiro Hasegawa, 1991, Endocrinologia japonica.

Unmasking of latent hypoparathyroidism in a child with partial DiGeorge syndrome by ethylenediaminetetraacetic acid infusion

T. Hasegawa, S. Koto, S. Asamura, 1993, European Journal of Pediatrics.